Medications for Smith-Magenis Syndrome
These are drugs that have been approved by the US Food and Drug Administration (FDA), meaning they have been determined to be safe and effective for use in Smith-Magenis Syndrome.
Found 1 Approved Drug for Smith-Magenis Syndrome
Tasimelteon
Brand Names
Hetlioz LQ, Hetlioz
Tasimelteon
Brand Names
Hetlioz LQ, Hetlioz
Form: Suspension, Capsule
Method of administration: Oral
FDA approval date: April 04, 2014
Classification: Melatonin Receptor Agonist
HETLIOZ is a melatonin receptor agonist. HETLIOZ capsules are indicated for the treatment of: Non-24-Hour Sleep-Wake Disorder (Non-24) in adults ( 1 ) Nighttime sleep disturbances in Smith-Magenis Syndrome (SMS) in patients 16 years of age and older ( 1 ) HETLIOZ LQ oral suspension is indicated for the treatment of: Nighttime sleep disturbances in SMS in pediatric patients 3 years to 15 years of age ( 1 )
Showing 1-1 of 1
Not sure about your diagnosis?
Check Your Symptoms
Tired of the same old research?
Check Latest Advances